Mindfulness IN-home for Diabetes and Sleep Health (MINDS)
Primary Purpose
Diabetes, Diabetes Mellitus, Type 2
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Mindfulness-based stress reduction (MBSR) Intervention
Sponsored by

About this trial
This is an interventional prevention trial for Diabetes focused on measuring Diabetes, Mindfulness, Public health, Sleep
Eligibility Criteria
Inclusion Criteria:
- Resident in the Atlanta, Georgia area
- Proficient in English
- Have a smartphone
- Sleep quality score >5 on the validated Pittsburgh Sleep Quality Index
- Prediabetes (defined as fasting glucose between 100-125 mg/dL or HbA1c between 5.7-6.4%)
Exclusion Criteria:
- Pregnant women
- Sleep quality score less than a score 5 on the validated Pittsburgh Sleep Quality Index
- Refusal to download Mindfulness mobile application
- Diagnosis of HIV, AIDS, Liver disease (diagnosed, i.e. chronic or alcoholic hepatitis, cirrhosis), Renal/Kidney disease
- Current Cocaine, heroin, or methamphetamines use and/or has a history of treatment for alcohol or drug abuse
- Pre-diabetes: defined as a score greater than 3 on the American Diabetes Association 60-Second Type 2 Diabetes Risk Test
Sites / Locations
- Emory University
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Mindfulness Intervention Arm
Arm Description
A stress reduction plus sleep education intervention to improve sleep health
Outcomes
Primary Outcome Measures
Pittsburgh Sleep Quality Index (PSQI) Score
Global sleep quality was measured via the validated Pittsburgh Sleep Quality Index (PSQI). The PSQI is a self-rated questionnaire which assesses several dimensions of sleep including sleep quality, duration, and disturbances over a 1-month time interval. In scoring the PSQI, seven component scores are derived, each scored 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score which ranges from 0 to 21. Poor sleep quality is defined as a global score of 5 or greater.
Sleep Duration
Sleep duration was measured in hours and minutes using a sleep 7-day actigraphy (Philips Respironics Actiwatch Spectrum Plus) on the non-dominant wrist, and confirmed with daily sleep logs. Self-reported sleep duration was also measured.
Perceived Stress Scale (PSS)
The perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress.
Number of Participants With PSS Score Indicating Low Stress
The perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress. Participants with scores of 0 to 13 are categorized as having low stress.
Number of Participants With PSS Score Indicating Moderate Stress
The perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress. Participants with scores of 14 to 26 are categorized as having moderate stress.
Number of Participants With PSS Score Indicating High Stress
The perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress. Participants with scores of 27 to 40 are categorized as having high stress.
Secondary Outcome Measures
Weight
Participants provided their weight in pounds (lbs) based on a scale that was distributed to participants.
Body Mass Index (BMI)
Body mass index (BMI) is calculated as weight in kilograms (kg) divided by the square of the body height measured in meters (m). A BMI between 18.5 and 24.9 is considered to be normal weight. A BMI of 25-29.9 indicates overweight, while a BMI of 30 or more indicates obesity.
Blood Pressure
Blood pressure is the pressure of circulating blood on the walls of blood vessels and is measured in millimeters of mercury (mmHg). Three seated blood pressure measurements were made using an electronic sphygmomanometer. An average of the last two readings were used to assess systolic and diastolic blood pressure. Blood pressure values of less than 120 mmHg systolic and 80 mmHg diastolic are considered within the normal range.
Full Information
NCT ID
NCT04160078
First Posted
November 8, 2019
Last Updated
September 13, 2022
Sponsor
Emory University
Collaborators
Georgia Center for Diabetes Translation Research, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
1. Study Identification
Unique Protocol Identification Number
NCT04160078
Brief Title
Mindfulness IN-home for Diabetes and Sleep Health
Acronym
MINDS
Official Title
Adapting a Mindfulness Intervention to Improve Sleep and Reduce Diabetes Risk Among a Diverse Sample in Atlanta
Study Type
Interventional
2. Study Status
Record Verification Date
September 2022
Overall Recruitment Status
Completed
Study Start Date
December 18, 2019 (Actual)
Primary Completion Date
August 17, 2021 (Actual)
Study Completion Date
August 29, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Emory University
Collaborators
Georgia Center for Diabetes Translation Research, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The study investigates the effects of a mindfulness intervention on sleep and subsequent cardio-metabolic risk in an adult Atlanta population aged 18 and older.
Detailed Description
Type 2 diabetes mellitus has been identified as a leading cause of death in the United States. This problem is alarmingly higher in southern state, including Georgia. Sleep, a modifiable health behavior, may be a target for reducing the burden of diabetes. This research study will enroll adults from the community to participate in a mindfulness-based stress reduction program (MBSR) via an app on his/her cellular phone. Participants will also wear a wrist monitor to estimate activity and sleep as well as provide a blood sample before and after the MBSR. Following the 6-week intervention program, participants will provide information via focus groups to obtain feedback on his/her experiences during the program.
This pilot study will enroll (N=20) racially diverse men and women who are 18 years and older and reside in Atlanta. Participants will be recruited from the community via advertisements, community events and existing community partnerships. Trained research assistants will screen potential participants. Eligible participants will be contacted via phone and scheduled to attend a baseline visit to collect a blood sample and attend a sleep education session.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes, Diabetes Mellitus, Type 2
Keywords
Diabetes, Mindfulness, Public health, Sleep
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
18 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Mindfulness Intervention Arm
Arm Type
Experimental
Arm Description
A stress reduction plus sleep education intervention to improve sleep health
Intervention Type
Behavioral
Intervention Name(s)
Mindfulness-based stress reduction (MBSR) Intervention
Other Intervention Name(s)
MBSR Intervention
Intervention Description
1-hour session on sleep hygiene and 7-week follow up using a mindfulness app, an app that features guided meditation and can be used to assess adherence.
Sleep log diary: self report of sleep records
Wrist Actigraphy, to monitor sleep patterns. Participants will be instructed on wearing the sleep monitor (Spectrum, Philips Respironics, Murrysville, PA) on their non-dominant wrist for the next 7-weeks
Primary Outcome Measure Information:
Title
Pittsburgh Sleep Quality Index (PSQI) Score
Description
Global sleep quality was measured via the validated Pittsburgh Sleep Quality Index (PSQI). The PSQI is a self-rated questionnaire which assesses several dimensions of sleep including sleep quality, duration, and disturbances over a 1-month time interval. In scoring the PSQI, seven component scores are derived, each scored 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score which ranges from 0 to 21. Poor sleep quality is defined as a global score of 5 or greater.
Time Frame
Baseline, 4 weeks post-intervention
Title
Sleep Duration
Description
Sleep duration was measured in hours and minutes using a sleep 7-day actigraphy (Philips Respironics Actiwatch Spectrum Plus) on the non-dominant wrist, and confirmed with daily sleep logs. Self-reported sleep duration was also measured.
Time Frame
Baseline, 4 weeks post-intervention
Title
Perceived Stress Scale (PSS)
Description
The perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress.
Time Frame
Baseline, 4 weeks post-intervention
Title
Number of Participants With PSS Score Indicating Low Stress
Description
The perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress. Participants with scores of 0 to 13 are categorized as having low stress.
Time Frame
Baseline, 4 weeks post-intervention
Title
Number of Participants With PSS Score Indicating Moderate Stress
Description
The perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress. Participants with scores of 14 to 26 are categorized as having moderate stress.
Time Frame
Baseline, 4 weeks post-intervention
Title
Number of Participants With PSS Score Indicating High Stress
Description
The perceived stress scale is a validated tool to help understand how different situations affect feelings and perceived stress. The PSS has 10 items which are responded to on a 5-point scale where 0 = never and 4 = very often. Total scores range from 0 to 40 and higher scores indicate higher perceived stress. Participants with scores of 27 to 40 are categorized as having high stress.
Time Frame
Baseline, 4 weeks post-intervention
Secondary Outcome Measure Information:
Title
Weight
Description
Participants provided their weight in pounds (lbs) based on a scale that was distributed to participants.
Time Frame
Baseline, 4 weeks post-intervention
Title
Body Mass Index (BMI)
Description
Body mass index (BMI) is calculated as weight in kilograms (kg) divided by the square of the body height measured in meters (m). A BMI between 18.5 and 24.9 is considered to be normal weight. A BMI of 25-29.9 indicates overweight, while a BMI of 30 or more indicates obesity.
Time Frame
Baseline, 4 weeks post-intervention
Title
Blood Pressure
Description
Blood pressure is the pressure of circulating blood on the walls of blood vessels and is measured in millimeters of mercury (mmHg). Three seated blood pressure measurements were made using an electronic sphygmomanometer. An average of the last two readings were used to assess systolic and diastolic blood pressure. Blood pressure values of less than 120 mmHg systolic and 80 mmHg diastolic are considered within the normal range.
Time Frame
Baseline, 4 weeks post-intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Resident in the Atlanta, Georgia area
Proficient in English
Have a smartphone
Sleep quality score >5 on the validated Pittsburgh Sleep Quality Index
Prediabetes (defined as fasting glucose between 100-125 mg/dL or HbA1c between 5.7-6.4%)
Exclusion Criteria:
Pregnant women
Sleep quality score less than a score 5 on the validated Pittsburgh Sleep Quality Index
Refusal to download Mindfulness mobile application
Diagnosis of HIV, AIDS, Liver disease (diagnosed, i.e. chronic or alcoholic hepatitis, cirrhosis), Renal/Kidney disease
Current Cocaine, heroin, or methamphetamines use and/or has a history of treatment for alcohol or drug abuse
Pre-diabetes: defined as a score greater than 3 on the American Diabetes Association 60-Second Type 2 Diabetes Risk Test
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dayna Johnson, PhD
Organizational Affiliation
Emory University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Emory University
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30322
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Statistical analysis plan will be available upon request. Data will be available one year after the first person is enrolled with no end date.
IPD Sharing Time Frame
One year after the first person is enrolled. No end date.
IPD Sharing Access Criteria
Researchers upon request will be able to access data, for any purpose. Data will be shared via secure data transfer.
Learn more about this trial
Mindfulness IN-home for Diabetes and Sleep Health
We'll reach out to this number within 24 hrs